1. Articles from retinalphysician.com

  2. 1-6 of 6
    1. Second-Generation OCT Module Goes the Extra Mile

      Second-Generation OCT Module Goes the Extra Mile

      Device features increased speed and higher image contrast. D avid M. Brown, MD, a retinal physician with Retina Consultants of Houston, in Texas, was prompted to upgrade to Heidelberg Engineering’s OCT2 module for the Spectralis diagnostic imaging platform because of its increased scanning speed and throughput. “I increasingly found that the process of obtaining optical coherence tomography (OCT) caused patient flow to bottleneck at my practice,” he says. “The OCT2 module helps to mitigate that issue. I can obtain a complete volume scan within 12 to 15 seconds for each eye that is precisely image tracked to the last ...

      Read Full Article
    2. Clinical Case of the Month Leica Microscope with OCT Guidance

      Clinical Case of the Month Leica Microscope with OCT Guidance

      "I have used Leica microscopes for over 12 years. Leica's ability to customize their platform to my needs has been very valuable given my particular needs. As a retina surgeon I rely heavily on my microscope for highresolution visualization during surgery. Leica's introduction of an integrated OCT will serve as an important tool in my educational efforts and I believe that patient outcomes may be enhanced. This technology will surely aid us in our understanding of the vitreoretinal interface and other retinal pathologies requiring surgery."

      Read Full Article
      Mentions: Leica
    3. Multimodal Imaging: Redefining Retinal Disease With Current Technology

      Multimodal Imaging: Redefining Retinal Disease With Current Technology

      Ophthalmic imaging has long been a mainstay of the diagnosis and treatment of eye disease. This aspect of retinal specialists’ practice has undergone many recent advances, leading to an expanding structural understanding of disease processes. The combination of multiple imaging modalities has helped retinal physicians to further understand disease progression and treatment response. In the era of multimodal imaging, recent observations have helped to clarify the underlying pathogenesis of many retinal diseases. Each imaging “modality” has tissue-specific characteristics that have allowed for the redefinition of many common retinal conditions and have led to an evolution of our understanding of vitreoretinal ...

      Read Full Article
    4. Ophthalmic OCT Reaches $1 Billion Per Year: But reimbursement clampdown clouds future innovation.

      Ophthalmic OCT Reaches $1 Billion Per Year: But reimbursement clampdown clouds future innovation.

      Long gone are the days when a new medical product could be easily introduced based solely on improved patient outcomes. To optimize the probability of success, a new product now needs to demonstrate that it can both improve patient outcomes and reduce costs. To the clinical practice manager, an attractive product will need to recoup its cost in the near term and generate revenues in a predictable and easily quantifiable manner, in addition to improving the quality of care. Optical coherence tomography has been an unqualified success in ophthalmology, where it is in daily use worldwide. There are tens of ...

      Read Full Article
    5. A Brave New World: The retina subspecialty is in the vanguard of changes to clinical practice and reimbursement

      A Brave New World: The retina subspecialty is in the vanguard of changes to clinical practice and reimbursement
      Ophthalmologists specializing in the management of retinal diseases exist in a brave new world. In the Aldous Huxley novel of that title, the society of the future threatens individuality. One could argue that limitations placed on physicians by CMS, third-party payers, regulators and the legal system likewise restrict our ability to practice medicine as we see fit. One of the limitations of our training is that it does not specifically prepare us to manage our practices as financial entities. Tradi tionally, we focus on patient care and offer services that we believe are of most benefit to patients. Over the ...
      Read Full Article
    6. New Technology: Bioptigen SDOCT Boosts Flexibility

      New Technology: Bioptigen SDOCT Boosts Flexibility

      Technology features a hand-held probe, presenting new opportunities for researchers and clinicians. With the introduction of spectral domain optical coherence tomography (SDOCT), clinicians and researchers now can noninvasively image ocular structures much more quickly and in unprecedented three-dimensional detail. One contender in the growing spectral domain market, the Bioptigen SDOCT, provides a novel feature—hand-held imaging—opening a new world of capabilities to researchers and clinicians, in addition to the advantages of rapid acquisition of high-quality depth-resolved images, superior resolution and real-time imaging. "We are focused on providing our system to specialists and lead adopters who really care about providing ...

      Read Full Article
    1-6 of 6
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks